Operating Lease, Right-of-Use Asset in USD of REGENERX BIOPHARMACEUTICALS INC from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
REGENERX BIOPHARMACEUTICALS INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q1 2023.
  • REGENERX BIOPHARMACEUTICALS INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2023 was $57.8K, a 257% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

REGENERX BIOPHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $57.8K +$41.6K +257% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $69.5K +$41.8K +151% 31 Dec 2022 10-Q 15 May 2023
Q3 2022 $75.8K +$37.2K +96.5% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $4.15K -$44.8K -91.5% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $16.2K -$42.6K -72.5% 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $27.7K -$40.6K -59.4% 31 Dec 2021 10-K 11 Apr 2023
Q3 2021 $38.6K -$38.6K -50% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $49K -$33K -40.3% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 $58.8K +$44.5K +310% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $68.2K +$43.8K +179% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $77.2K +$43.1K +127% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $82K +$38.9K +90.3% 30 Jun 2020 10-K 02 Mar 2021
Q1 2020 $14.4K -$37.3K -72.2% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $24.5K +$24.5K 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 $34K 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $43.1K 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $51.7K 31 Mar 2019 10-Q 15 May 2019
Q4 2018 $0 31 Dec 2018 10-K 20 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.